Overview
- By Thursday, overall bids reached 23% of the offer, with QIBs at 30%, retail at 25%, NIIs at 11% and the employee quota at 64%, according to the latest tallies.
- The Rs 871.05 crore issue is priced at Rs 438–460 per share, combining a Rs 353.4 crore fresh issue with an OFS of about Rs 517.6 crore, with proceeds earmarked for new clinics, debt repayment and corporate purposes.
- The company raised Rs 260 crore from anchors by allotting 56.58 lakh shares at Rs 460 to 14 institutions including SBI MF, ICICI Prudential MF, Fidelity Funds, DSP MF, Bandhan MF, SBI Life Insurance and HDFC Life Insurance.
- Secondary transactions of roughly Rs 136 crore on Dec. 8–9 provided liquidity to early shareholders, with investors such as TIMF Holdings, Axis Max Life Insurance, Akash Bhanshali, Malabar India Fund and Motilal Oswal India Excellence Fund participating.
- The stock is slated to list on Dec. 17, as the dialysis network highlights scale of 519 clinics globally and reported FY25 revenue of Rs 756 crore with PAT of Rs 67 crore.